Company: CYTK
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-267059
Chunk: 14

Company: CYTOKINETICS INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Part II, Item 5
Chunk 14
---
 conditions of Rule 10b5-1 under the Exchange Act or may constitute non-Rule 10b5–1 trading arrangements. In addition, certain of our directors have made elections to participate in, and are participating in, our director equity in lieu of cash retainer option program (as described in the “Director Compensation” section of our Proxy Statement for our 2024 Annual Meeting), which may be designed to satisfy the affirmative defense conditions of Rule 10b5-1 under the Exchange Act or may constitute non-Rule 10b5–1 trading arrangements.